| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2012-05-24 | PNB01 | major depressive disorder (MDD) | 3 | PharmaNeuroBoost (Belgium) | CNS diseases - Mental diseases |
| 2012-05-23 | lisdexamfetamine dimesylate | Attention-Deficit Hyperactivity Disorder (ADHD)
|
3 | Shire (UK-USA) | CNS diseases - Mental diseases |
| 2012-05-23 | PD-protec™ | kidney failure |
1-2 | Zytoprotec (Germany) | Kidney diseases - Renal diseases |
| 2012-05-22 | Nexavar® (sorafenib) | non-small cell lung cancer (NSCLC) |
3 | Bayer (Germany) Onyx Pharmaceuticals (USA) | Cancer - Oncology |
| 2012-05-22 | tiotropium | asthma | 2 | Boehringer Ingelheim (Germany) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2012-05-22 | prediction test | inflammatory bowel disease | Prometheus Laboratories (USA - part of Nestlé Health Science - Switzerland) | Inflammatory diseases | |
| 2012-05-21 | olodaterol | chronic obstructive pulmonary disease (COPD) | 2 | Boehringer Ingelheim (Germany) | Respiratory diseases |
| 2012-05-18 | dabrafenib | melanoma |
1 | GSK (UK) | Cancer - Oncology |
| 2012-05-17 | NVA237 (glycopyrronium bromide) | chronic obstructive pulmonary disease |
3 | Novartis (Switzerland) | Respiratory diseases |
| 2012-05-17 | combination of vandetanib and selumetinib | advanced solid tumours non-small cell lung cancer |
Cancer Research UK (UK) | Cancer - Oncology | |
| 2012-05-16 | VEGF-D adenoviral vector | refractory angina | 1 | Ark Therapeutics (UK) | Cardiovascular diseases |
| 2012-05-15 | PLX cells (PLacental eXpanded cells) | diabetic-induced diastolic dysfunction |
preclinical | Pluristem Therapeutics (Germany) | Cardiovascular diseases |
| 2012-05-15 | masitinib | gastrointestinal stromal tumor (GIST) | 3 | AB Science (France) | Cancer - Oncology |
| 2012-05-14 | remimazolam | sedation general anesthesia |
2 | Paion (Germany) Ono Pharmaceutical (Japan) | CNS diseases |
| 2012-05-14 | influenza vaccine using Isconova’s adjuvant product Matrix M™ | influenza | 1 | Isconova (Sweden) | Infectious diseases |
| 2012-05-10 | Vacc-4x and Endocine | HIV-Aids | 2b | Bionor Pharma (Norway) Eurocine Vaccines (Sweden) | Infectious diseases |
| 2012-05-09 | TG4001 | CIN2/3 intra-epithelial neoplasia of the cervix due to infection with high-risk human papillomavirus | 2 | Transgene (France) | Cancer - Oncology |
| 2012-05-08 | aganirsen (GS-101, eye drops) | retinal neovascular diseases such as wet age-related macular degeneration (AMD) and ischemic retinopathy | preclinical | Gene Signal (Switzerland) | Ophtalmological diseases |
| 2012-05-07 | pasireotide (SOM230) long-acting release (LAR) | acromegaly | 3 | Novartis (Switzerland) | Hormonal diseases - Rare diseases - Endocrine diseases |
| 2012-05-07 | dalcetrapib | 3 | Roche (Switzerland) |
